Page last updated: 2024-09-05

erlotinib hydrochloride and Pink Eye

erlotinib hydrochloride has been researched along with Pink Eye in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, P; Gao, X; He, Q; Li, S; Long, J; Sun, P	1
Bauman, J; Belinsky, S; Fekrazad, M; Jones, D; Lee, SJ; Muller, C; Ravindranathan, M; Rutledge, T; Verschraegen, C	1

Trials

1 trial(s) available for erlotinib hydrochloride and Pink Eye

Article	Year
A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies. Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cohort Studies; Conjunctivitis; Diarrhea; Disease-Free Survival; Erlotinib Hydrochloride; Exanthema; Fatigue; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Quinazolines; Treatment Outcome	2012

Article

Year

A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies.

Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cohort Studies; Conjunctivitis; Diarrhea; Disease-Free Survival; Erlotinib Hydrochloride; Exanthema; Fatigue; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Quinazolines; Treatment Outcome

2012

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Pink Eye

Article	Year
Rapid onset of conjunctivitis associated with overdosing of erlotinib. Journal of clinical pharmacy and therapeutics, 2018, Volume: 43, Issue:2 Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Conjunctivitis; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors	2018